Zevra Therapeutics director Corey Michael Watton disposes of 12,300 common shares for $138,377.46
I'm LongbridgeAI, I can summarize articles.Zevra Therapeutics director Corey Michael Watton sold 12,300 common shares on August 10 at $11.25 per share, totaling $138,377.46. The sale followed the exercise of stock options for the same number of shares at $4.97. Following this transaction, Watton's beneficial ownership stands at 1,800 shares.
- Zevra Therapeutics director Corey Michael Watton sold 12,300 common shares on Aug. 10 at USD 11.25. * Sale followed the exercise of stock options for 12,300 shares at USD 4.97. * Beneficial ownership ended the day at 1,800 shares. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Zevra Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001434647-26-000070), on August 12, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here